Rhythm control or ventricular response control in treating atrial fibrilation ?

Tomáš Janota

Interv Akut Kardiol. 2009;8(3):119-120  

Is angioplasty for atherosclerotic renal artery stenosis beneficial in managing hypertension ?

Ivo Varvařovský, Aleš Herman, Jan Matějka, Vladimír Rozsíval

Interv Akut Kardiol. 2009;8(3):121-123  

Introduction: Renal artery stenosis may result in an increase in blood pressure and the development of renal insufficiency; however, the dilatation of stenosis using renal angioplasty has an indeterminate effect on the course of these conditions. Objective: To assess the effect of percutaneous transluminal renal artery angioplasty (PTRA) on the course of hypertensive disease. Methods: A retrospective study of the course of hypertensive disease in patients managed with PTRA at a single centre. Results: In 26 patients, there was a significant decrease in the systolic (from 159 to 143 mm Hg, p = 0.02), diastolic (from 84 to 78 mm Hg, p = 0.04) as...

Dual center register of transradial primary percutaneous coronary interventions

Ivo Bernat, David Horák, Jiří Koza, Jan Pešek, Vladimír Hraboš, Zdeněk Šembera, Radomír Šimek, Michal Šmíd, Rostislav Polášek, Richard Rokyta

Interv Akut Kardiol. 2009;8(3):124-126  

The aim of this study was to analyse the results of primary percutaneous coronary interventions (pPCI) from two centers with high experience in transradial PCI. Transradial approach was feasible in 80 % of patients with acute myocardial infarction with ST segment elevations (STEMI) without cardiogenic shock in both centers with absence of severe local bleeding complications.

Estimation of left ventricular filling pressure using echocardiography

prof. MUDr. Jaroslav Meluzín CSc

Interv Akut Kardiol. 2009;8(3):128-133  

Left ventricular filling pressure (LVFP) is of utmost importance for the adequate diastolic filling of the left ventricle (LV). The determination of LVFP allows to diagnose primary diastolic heart failure, to assess prognosis of patients with congestive heart failure, and to predict the risk of acute heart failure decompensation. Echocardiography is the most frequently utilized noninvasive method in determining LVFP. Pulsed Doppler echocardiography allows to measure the peak velocity of LV filling in early diastole (E), Doppler tissue echocardiography enables to quantify the peak velocity of early diastolic annular motion (Ea). The E/Ea ratio has...

Myocardial rupture as a mechanical complication of acute myocardial infarction

Martin Novák, Ota Hlinomaz, Jan Černý

Interv Akut Kardiol. 2009;8(3):135-140  

Myocardial rupture is serious potencially fatal complication of acute myocardial infarction. The key to management is an aggressive approach to hemodynamic stabilization and early surgery. In some patients with ventricular septal rupture or subacute left ventricular free wall rupture transcatheter treatment can be considered as alternative to surgery.

Peripartum cardiomyopathy

Zdeněk Monhart, Jan Sedláček

Interv Akut Kardiol. 2009;8(3):142-143  

Peripartum cardiomyopathy is a rare disorder in which left ventricular dysfunction and symptoms of heart failure occur in the peripartum period in previously healthy women. The etiology of peripartum cardiomyopathy remains uncertain. We present a case of a 44-year old female with acute heart failure in the early postpartum period. Intitial severe left ventricular dysfunction normalized within two months. The patient has full functional recovery after one year, being treated with betablocker and ACE inhibitor.

Persistent ductus arteriosus as a rare cause of severe pulmonary hypertension in elderly patients

Jiří Fismol, Jaroslav Januška, Libor Škňouřil, Piotr Branny, Marian Branny, Martin Fiala

Interv Akut Kardiol. 2009;8(3):144-147  

Patent ductus arteriosus (PDA) is rarely diagnosed in adults, especially in seniors. When associated with hemodynamically significant shunt, it may cause chronic cardiac failure and pulmonary hypertension. We present two patients with hemodynamically significant PDA and severe pulmonary hypertension, who were treated by catheter-based closure of this congenital heart defect.

Fondaparinux

Ondřej Dostál, doc. MUDr. Debora Karetová CSc, MUDr. Lenka Skalická, Jean-Claude Lubanda

Interv Akut Kardiol. 2009;8(3):149-152  

Fondaparinux is a new drug which belongs to parenteral anticoagulants. The efficacy and safety of this drug were proven in numerous clinical trials for several indications. Fondaprinux is a synthetic and specific inhibitor of activated factor X in the coagulation cascade. In comparison to unfractionated heparin (UFH) and low molecular weight heparins (LMWH), fondaparinux does not interact with thrombin. Its main advantage is the long half time which allows once daily administration. On the other hand, the main disadvantage is the high renal dependence of its clearance. The drug is indicated for prophylaxis of thromboembolic disease in patients...

17th Annual meeting of the Czech Society of Cardiology - comments on selected papers on cardiac arrythmias

Kateřina Lefflerová

Interv Akut Kardiol. 2009;8(3):155-156  

Interventional cardiology report from the 17th Annual meeting of the Czech Society of Cardiology held in Brno between May 10 and 13, 2009

Petr Kala, Martin Mates

Interv Akut Kardiol. 2009;8(3):157  

An overview of papers dealing with accute cardiology issues at the 17th Annual meeting of the Czech Society of Cardiology

Tomáš Janota

Interv Akut Kardiol. 2009;8(3):158  

Thirtieth annual conference of the Hearth Rhythm Society

Vlastimil Vančura

Interv Akut Kardiol. 2009;8(3):159-160  

12th Prague Workshop on Catheter Ablation with Live Demonstrations

Petr Pařízek, Luděk Haman

Interv Akut Kardiol. 2009;8(3):161-162